BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Drug Development

  Curis, Inc. Announces Dosing Of First Patient In Phase 1 Trial Of CUDC-907 In Patients With Advanced/ Relapsed Solid Tumors

  December 18, 2014

   · 

  6 min read
• Drug Development

  Fate Therapeutics Announces Interim Data From Ongoing Phase 2 PUMA Study

  December 18, 2014

   · 

  13 min read
• Drug Development

  Biocryst Pharmaceuticals Initiates Opus-2: A Clinical Trial Of BCX4161 In Patients With Hereditary Angioedema

  December 18, 2014

   · 

  5 min read
• Genetown

  Aldeyra Therapeutics Submits FDA IND Filing for Noninfectious Anterior Uveitis

  December 18, 2014

   · 

  4 min read
• Biotech Bay

  MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Completes Public Offering of Common Stock

  December 18, 2014

   · 

  3 min read
• Drug Development

  StemCells Inc. Transplants First Participant In Phase 2 Clinical Trial In Cervical Spinal Cord Injury

  December 18, 2014

   · 

  8 min read
• Pharm Country

  PTC Therapeutics, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  December 18, 2014

   · 

  1 min read
• Trillium Therapeutics Inc. To List Common Shares On The NASDAQ Capital Market Under The Symbol TRIL

  December 18, 2014

   · 

  2 min read
• BioMidwest

  Oasis Health Products, Inc. Announces Completion Of Stability Testing On Itonis, Inc.'s EMESYL Nausea Relief

  December 18, 2014

   · 

  1 min read
• Pharm Country

  PHARNEXT Announces Pleotherapy Proof Of Concept In Charcot-Marie-Tooth Disease Type 1A Through Two Peer-Reviewed Publications

  December 18, 2014

   · 

  4 min read